The Company has research collaborations with various academic centres aimed at further understanding the mode of action and clinical potential of Tonabersat and Sabcomeline.

These include:

Tonabersat

• Professor Andrew Charles, University of California at Los Angeles
• Dr Michael Rogawski, US National Institutes of Health
• Professor Paul Durham, Missouri State University, Springfield

Sabcomeline

• Professor Herb Meltzer, Vanderbilt University, Nashville